Results 151 to 160 of about 38,385 (190)

Clostridium difficile Recombinant Toxin A Repeating Units as a Carrier Protein for Conjugate Vaccines: Studies of Pneumococcal Type 14, Escherichia coli K1, and Shigella flexneri Type 2a Polysaccharides in Mice

, 2000
Danka Pavliakova, J. Scott Moncrief, David M. Lyerly, Gerald Schiffman, Dolores A. Bryla, John B. Robbins, Rachel Schneerson   +6 more
openalex   +1 more source

Recent Trends in Invasive Pneumococcal Disease in Korea in the Post-pneumococcal Vaccine Era. [PDF]

Ann Lab Med, 2023
Huh HJ, Sung H.
europepmc   +1 more source

Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016-2018-The ECAPS study. [PDF]

Front Public Health, 2023
Hansen K, Rünow E, Torisson G, Theilacker C, Palmborg A, Pan K, Jiang Q, Southern J, Beavon R, Gessner BD, Riesbeck K, Ahl J.   +11 more
europepmc   +1 more source

Towards a Synthetic Pneumococcal Vaccine: Synthetic Oligosaccharides as Tools for Improving the Specificity of Enzyme-Linked Immunosorbent Assays

, 2000
H. Snippe, Wouter T. M. Jansen, Johannis P. Kamerling, Dirk J. Lefeber   +3 more
openalex   +1 more source

Regional differences in pediatric pneumococcal vaccine schedules for Indigenous children in Canada: an environmental scan. [PDF]

BMC Health Serv Res
Mahon S, Reifferscheid L, Kenzie L, MacDonald SE.   +3 more
europepmc   +1 more source

Evolution of Pneumococcal Vaccine Recommendations and Criteria for Decision Making in 5 Western European Countries and the United States. [PDF]

MDM Policy Pract, 2023
Noharet-Koenig R, Lasota K, Faivre P, Langevin E.   +3 more
europepmc   +1 more source

PHV15: CLINICAL AND ECONOMIC BENEFITS OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN

, 2000
Gerry Oster, Derek Weycker, Vincent Ciuryla, Edward P. Richardson, Dorothea K. Thompson   +4 more
openalex   +1 more source

Skin exposure to soil microbiota elicits changes in cell-mediated immunity to pneumococcal vaccine. [PDF]

Sci Rep
Roslund MI, Nurminen N, Oikarinen S, Puhakka R, Grönroos M, Puustinen L, Kummola L, Parajuli A, Cinek O, Laitinen OH, Hyöty H, Sinkkonen A.   +11 more
europepmc   +1 more source

A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population. [PDF]

Hum Vaccin Immunother, 2022
Yunhua B, Peng B, Shuping L, Zheng Z.
europepmc   +1 more source

Rationale for a hospital-based pneumococcal vaccine trial for HIV-seropositive South Africans

, 2000
Raymond A. Smego, Gemma Genovese, Keith P. Klugman   +2 more
openalex   +1 more source